In the United States (US), private-supply tapwater (TW)
is rarely
monitored. This data gap undermines individual/community risk-management
decision-making, leading to an increased probability of unrecognized
contaminant exposures in rural and remote locations that rely on private
wells. We assessed point-of-use (POU) TW in three northern plains
Tribal Nations, where ongoing TW arsenic (As) interventions include
expansion of small community water systems and POU adsorptive-media
treatment for Strong Heart Water Study participants. Samples from
34 private-well and 22 public-supply sites were analyzed for 476 organics,
34 inorganics, and 3 in vitro bioactivities. 63 organics and 30 inorganics
were detected. Arsenic, uranium (U), and lead (Pb) were detected in
54%, 43%, and 20% of samples, respectively. Concentrations equivalent
to public-supply maximum contaminant level(s) (MCL) were exceeded
only in untreated private-well samples (As 47%, U 3%). Precautionary
health-based screening levels were exceeded frequently, due to inorganics
in private supplies and chlorine-based disinfection byproducts in
public supplies. The results indicate that simultaneous exposures
to co-occurring TW contaminants are common, warranting consideration
of expanded source, point-of-entry, or POU treatment(s). This study
illustrates the importance of increased monitoring of private-well
TW, employing a broad, environmentally informative analytical scope,
to reduce the risks of unrecognized contaminant exposures.